消化管カルチノイド
WordNet
- of or relating to the stomach and intestines; "a gastrointestinal disorder" (同)GI
- a small tumor (benign or malignant) arising from the mucosa of the gastrointestinal tract; usually associated with excessive secretion of serotonin
PrepTutorEJDIC
- 胃腸の,胃腸に影響する
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- MEN1 c.825‑1G>A mutation in a family with multiple endocrine neoplasia type 1: A case report.
- Ning Z1, Wang O1, Meng X1, Xing X1, Xia W1, Jiang Y1, Li M1, Xu Y2.
- Molecular medicine reports.Mol Med Rep.2015 Oct;12(4):6152-6. doi: 10.3892/mmr.2015.4138. Epub 2015 Jul 29.
- Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease characterized by combined occurrence of tumors and hyperplasia in tissues including the parathyroid, gastrointestinal endocrine tissue and anterior pituitary. Heterozygous germline mutation of the tumor suppressor gene MEN1
- PMID 26239674
- Role of computed tomography angiography in detection and staging of small bowel carcinoid tumors.
- Bonekamp D1, Raman SP1, Horton KM1, Fishman EK1.
- World journal of radiology.World J Radiol.2015 Sep 28;7(9):220-35. doi: 10.4329/wjr.v7.i9.220.
- Small-bowel carcinoid tumors are the most common form (42%) of gastrointestinal carcinoids, which by themselves comprise 70% of neuroendocrine tumors. Although primary small bowel neoplasms are overall rare (3%-6% of all gastrointestinal neoplasms), carcinoids still represent the second most common
- PMID 26435774
- Long-term results of PRRT in advanced bronchopulmonary carcinoid.
- Mariniello A1, Bodei L2, Tinelli C3, Baio SM2, Gilardi L2, Colandrea M2, Papi S2, Valmadre G4, Fazio N5, Galetta D6, Paganelli G7, Grana CM2.
- European journal of nuclear medicine and molecular imaging.Eur J Nucl Med Mol Imaging.2015 Sep 21. [Epub ahead of print]
- PURPOSE: Peptide receptor radionuclide therapy (PRRT) for the treatment of neuroendocrine tumours (NET) has been explored for almost two decades, but there are still few trials that have exclusively investigated well-differentiated and moderately differentiated NET arising from the respiratory tree.
- PMID 26392198
Japanese Journal
- CPT-11/MMC併用療法が有効であった胃真性癌肉腫の1例
- 宮川 明祐,石橋 啓如,高科 亜弓,石垣 和祥,岩井 優,阿部 宏美,片桐 智子,坂口 賀基,松島 知広,田村 寿英,小又 誠一,窪田 学,鈴木 良夫,中村 朗,糸林 詠,紫村 治久,志村 謙次
- Nippon Shokakibyo Gakkai Zasshi 111(1), 105-114, 2014
- 59歳男性.黒色便を契機に上部消化管内視鏡検査を施行.噴門部直下に潰瘍をともなう隆起性病変を認め,生検で腺癌と診断された.急速に増大し,肝転移も認めたが,出血管理目的に胃全摘術を施行した結果,骨肉腫への分化をともなう真性癌肉腫と診断された.S-1/CDDP併用療法は無効であったがCPT-11/MMC併用療法を3コース施行し,部分奏効を得た.同レジメンが骨肉腫への分化をともなう胃癌肉腫に有効であった …
- NAID 130003383337
- A型胃炎を背景に早期胃癌とカルチノイドが併存した病変をESDで切除し得た1例
- 高住 美香,石幡 良一,紺野 直紀,渡辺 研也,高野 真,猪狩 弘之,内海 康文,村島 正泰,引地 拓人,小原 勝敏,大平 弘正
- 日本消化器内視鏡学会雑誌 55(3), 450-458, 2013
- 69歳,男性.市民検診にて胃の隆起性病変を指摘され,精査加療目的に当科を受診した.内視鏡検査では胃体上部大弯後壁側に上皮性変化を伴う3cm大の亜有茎性腫瘍を認め,早期胃癌と考えESDを施行した.病理組織にて胃癌とカルチノイドが同一病変内に併存している所見を認め,背景粘膜には非腫瘍性内分泌小胞巣が認められた.さらに本例では,胃体部粘膜の萎縮,高ガストリン血症,抗胃壁細胞抗体陽性を認めA型胃炎と診断し …
- NAID 130003375266
- 小腸カルチノイドと小腸GISTを併発した神経線維腫症1型の1例
- 北出 貴嗣,園山 輝久,若狭 基見,山崎 茂樹,崔 聡仁,石原 陽介
- 日本臨床外科学会雑誌 = The journal of the Japan Surgical Association 73(11), 3003-3007, 2012-11-25
- NAID 10031147802
Related Links
- Whether you (or a loved one) are worried about developing a gastrointestinal carcinoid tumor, have just been diagnosed, are going through treatment, or are trying to stay well after treatment,this page can help you find the answers you ...
- Information about gastrointestinal carcinoid tumor: treatment, clinical trials, and other topics from the National Cancer Institute. ... A gastrointestinal (GI) carcinoid tumor is a slow-growing tumor that forms in the neuroendocrine cells ...
Related Pictures
![Gastrointestinal Carcinoid Tumors](https://1mg.info/0/5/9/2224.jpg)
![Pulmonary carcinoid tumor 10x](https://1mg.info/0/5/9/2225.jpg)
![gastrointestinal carcinoid risks and learn](https://1mg.info/0/5/9/2226.jpg)
![comments gastric carcinoids can exhibit a](https://1mg.info/0/5/9/2227.jpg)
![Carcinoid Tumour](https://1mg.info/0/5/9/2228.jpg)
★リンクテーブル★
[★]
- 英
- gastrointestinal carcinoid
- 関
- 消化管内分泌細胞腫瘍、カルチノイド、カルチノイド症候群
病理
- 好銀反応:陽性
- 免疫組織化学:NSE(+)、S-100蛋白(+)、クロモグラニン染色(+)
例外
- 直腸カルチノイド:好銀反応(-)、argentaffin反応(-)、セロトニン産生(-)
病態
治療
- 直径1cm以下:内視鏡下粘膜切除術、筋層を含む局所切除術
- 直径2cm以上:(転移率が高い)リンパ節郭清を伴う根治術、肝線維走の切除
参考
- http://ganjoho.jp/professional/med_info/evidence/list/edb_gastrointestinal_carcinoid.html
- 2. がん情報サイト|PDQ®日本語版(医療専門家向け)
- http://cancerinfo.tri-kobe.org/pdq/summary/japanese-s.jsp?Pdq_ID=CDR0000062893
[★]
- 胃腸の、胃腸管の、胃腸管系の
- 消化管の、消化器の、消化器系の
- 関
- alimentary canal、alimentary system、alimentary tract、digestive organ、digestive system、digestive tract、gastrointestinal system、gastrointestinal tract、GI、GI tract、intestinal
[★]
カルチノイド
- 同
- argentaffinoma